About the webinar:
The American Cancer Society estimated there would be more than 1.8 million new cancer cases diagnosed in 2020, an increase of 55% over the last 15 years. This correlates with an expected 58 million patient oncology clinic visits in the United States. The increase in cancer incidence and patients undergoing chemotherapy has exacerbated the need for oncology technicians to administer treatment and patient caregivers to act as a support system. Cancer is also the leading cause of death in dogs, with an estimated 1 in 3 dogs developing the disease. Similar to cancer incidence and chemotherapy treatment for humans, cancer chemotherapy for dogs has become more common. Dogs treated with antineoplastic drugs may act as a source of secondary exposure, but the extent of surface contamination from antineoplastic drugs is currently unclear. This research aims to quantify potential exposure to healthcare workers and dog-owners, and to better understand and characterize the health risks associated with workplace exposure to chemotherapy drugs. Achieving these goals will help to inform effective strategies to eliminate hazardous exposures in the clinic, as well as potential secondary home exposure.